Andere talen Jianmin Pharmaceutical Group Co.,Ltd.

Aandelen

600976

CNE000001HB7

slotkoers Shanghai S.E. Andere beurzen 00:00:00 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
50,5 ^CNY	-0,32%		-9,77%	-22,61%

19/04	Jianmin Pharmaceutical Group Co. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
15/03	Jianmin Pharmaceutical Group Co. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04
Jianmin Pharma Gets Nod to Market Asthma Drug	16/04
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Jianmin Pharmaceutical’s Drugs Remain Covered by China’s National Medical Insurance	15/12
Jianmin Pharmaceutical Earmarks 132 Million Yuan to Expand China Factory; Shares Jump 8%	17/11
Jianmin Pharma Gets Nod to Market Drug For Children's Acute Bronchitis	23-10-23
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	21-10-23
Jianmin Pharma Receives Nod to Market Oral Solution For Epilepsy Patients	17-10-23
Jianmin Pharmaceutical Group Co.,Ltd.(XSSC:600976) added to S&P Global BMI Index	18-09-23
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	08-08-23
Jianmin Pharmaceutical Group Co.,Ltd. completed the acquisition of 6.13% stake in HeraMED Limited from Hua Li Pharmaceutical Group Co.,Ltd.	25-07-23
Jianmin Pharma Gets Nod to Market Atomoxetine Hydrochloride Oral Solution; Shares Drop 3%	25-05-23
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	17-04-23
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	14-03-23
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	14-03-23
Jianmin Pharma's Liver, Stomach Disease Drug Included in China’s Medical Insurance Catalog	19-01-23
Jianmin Pharma to Buy 4.5% of Australia’s Hera Med for 8.4 Million Yuan	28-12-22
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	21-10-22
Jianmin Pharmaceutical Group Co.,Ltd. intends to acquire Zhejiang Huafang Medical Care Co., Ltd from Holley Group Company Limited, Zhejiang Holley Investment Management Co., Ltd. and Suzhou Yuanyi Zhiyuan Equity Investment Partnership (Limited Partnership) for CNY 15.2 million.	17-08-22
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	19-07-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Jianmin Pharmaceutical Group Co.,Ltd.

Aandelen

600976

CNE000001HB7

Andere talen

Filters